No. 22-37
 
Title: Teva Pharmaceuticals USA, Inc., Petitioner
v.
GlaxoSmithKline LLC, et al.
Docketed: July 13, 2022
Linked with: 21A677
Lower Ct: United States Court of Appeals for the Federal Circuit
   Case Numbers: (2018-1976, 2018-2023)
   Decision Date: August 5, 2021
   Rehearing Denied: February 11, 2022
 
Proceedings and Orders
Apr 29 2022 Application (21A677) to extend the time to file a petition for a writ of certiorari from May 12, 2022 to July 11, 2022, submitted to The Chief Justice.
Main Document Lower Court Orders/Opinions Lower Court Orders/Opinions Lower Court Orders/Opinions
May 03 2022 Application (21A677) granted by The Chief Justice extending the time to file until July 11, 2022.
Jul 11 2022 Petition for a writ of certiorari filed. (Response due August 12, 2022)
Petition Appendix Certificate of Word Count Proof of Service
Jul 25 2022 Motion to extend the time to file a response from August 12, 2022 to September 12, 2022, submitted to The Clerk.
Main Document
Jul 26 2022 Motion to extend the time to file a response is granted and the time is extended to and including September 12, 2022.
Aug 10 2022 Brief amici curiae of 42 Professors of Law, Economics, Business, and Medicine filed.
Main Document Proof of Service Certificate of Word Count
Aug 12 2022 Brief amicus curiae of Alvotech filed.
Main Document Proof of Service Certificate of Word Count
Aug 12 2022 Brief amicus curiae of Mylan Pharmaceuticals Inc. filed.
Main Document Proof of Service Certificate of Word Count
Aug 12 2022 Brief amicus curiae of Association for Accessible Medicines filed.
Main Document Proof of Service Certificate of Word Count
Aug 19 2022 Brief of respondents GlaxoSmithKline LLC, et al. in opposition filed.
Main Document Proof of Service Certificate of Word Count
Sep 07 2022 DISTRIBUTED for Conference of 9/28/2022.
Sep 07 2022 Reply of petitioner Teva Pharmaceuticals USA, Inc. filed. (Distributed)
Main Document Proof of Service Certificate of Word Count
Oct 03 2022 The Solicitor General is invited to file a brief in this case expressing the views of the United States.
Mar 29 2023 Brief amicus curiae of United States filed.
Main Document Certificate of Word Count
Apr 11 2023 Supplemental brief of respondents GlaxoSmithKline LLC, et al. filed. (Distributed)
Main Document Certificate of Word Count Proof of Service
Apr 12 2023 DISTRIBUTED for Conference of 4/28/2023.
May 08 2023 DISTRIBUTED for Conference of 5/11/2023.
May 15 2023 Petition DENIED. Justice Kavanaugh would grant the petition for a writ of certiorari.
Attorneys
Attorneys for Petitioners
William McGinley Jay
Counsel of Record
Goodwin Procter, LLP
1900 N Street, N.W.
Washington, DC 20036

WJay@goodwinlaw.com
Ph: 2023464190
Party name: Teva Pharmaceuticals USA, Inc.


Jaime Ann Santos
Goodwin Procter LLP
1900 N St. NW
Washington, DC 20036

JSANTOS@GOODWINLAW.COM
Ph: 2023464034
Party name: Teva Pharmaceuticals USA, Inc.


Attorneys for Respondents
Juanita R. Brooks
Counsel of Record
Fish & Richardson
12860 El Camino Real
Suite 400
San Diego, CA 92130

BROOKS@FR.COM
Ph: 858-678-5070
Party name: GlaxoSmithKline LLC, et al.


Other Attorneys
Elizabeth B. Prelogar
Counsel of Record
Solicitor General
United States Department of Justice
950 Pennsylvania Avenue, NW
Washington, DC 20530-0001

SUPREMECTBRIEFS@USDOJ.GOV
Ph: 202-514-2217
Party name: United States


Charles Duan
Counsel of Record
2701 Calvert St NW Apt 623
Washington, DC 20008

supremecourt.gov@cduan.com
Ph: (202) 525-5717
Party name: 42 Professors of Law, Economics, Business, and Medicine


Jonathan Yates Ellis
Counsel of Record
McGuireWoods LLP
888 16th Street N.W.
Suite 500
Washington, DC 20006

jellis@mcguirewoods.com
Ph: 202-828-2887
Party name: Alvotech


Matthew S. Hellman
Counsel of Record
Jenner & Block LLP
1099 New York Ave., NW
Suite 900
Washington, DC 20001

mhellman@jenner.com
Ph: 202-639-6000
Party name: Association for Accessible Medicines


Steffen Nathanael Johnson
Counsel of Record
Wilson Sonsini Goodrich & Rosati
1700 K Street, NW, Fifth Floor
Washington, DC 20006

sjohnson@wsgr.com
Ph: (202) 973-8888
Party name: Mylan Pharmaceuticals Inc.